Bendeka 100 mg/4 mL injection for intravenous infusion Images
Generic Name: bendamustine
This medication has been identified as Bendeka 100 mg/4 mL injection for intravenous infusion. It is supplied by Teva Pharmaceuticals USA, Inc.
Bendeka is used in the treatment of Non-Hodgkin's Lymphoma; Chronic Lymphocytic Leukemia and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Bendeka 100 mg/4 mL injection for intravenous infusion is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Bendeka
- Generic Name
- bendamustine
- Strength
- 100 mg/4 mL injection for intravenous infusion
- Availability
- Prescription only
- Drug Class
- Alkylating agents
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA, Inc.
- National Drug Code (NDC)
- 63459-0348
More about Bendeka (bendamustine)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: alkylating agents
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.